COMy 2019 | What is the future for myeloma clinical trials?
Mohamad Mohty
Mohamad Mohty, MD, PhD of Saint-Antoine Hospital, Paris, France, discusses the future of clinical trials for multiple myeloma, including a focus on smoldering myeloma and stopping the evolution of myeloma at an earlier stage, rather than after organ damage. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.
Similar topics
Related videos

Myeloma XI trial: increased progression-free survival
Charlotte Pawlyn

Pivotal STORM study: selinexor for penta-refractory multiple myeloma
Joshua Richter

Current challenges for multiple myeloma therapy: 2, 3, 4-drug combinations
Joshua Richter

Multiple myeloma musings: highlights from 2018 data
Joshua Richter

An exciting era for CAR T-cell therapy
Mohamad Mohty
More from Mohamad Mohty